A. B. M. Al-Mamun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
A. B. M. Al-Mamun has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Kaniz Fatema
Department of Transfusion Medicine, National Institute of Neuroscience and Hospital, Dhaka, Bangladesh
2 shared publicationsKashfia Islam
Associate Professor, Transfusion Medicine, Dhaka Medical College Hospital, Dhaka
2 shared publicationsM. Ashadul Islam
Department of Transfusion Medicine, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
2 shared publicationsTanzin Ara Karim
Assistant Registrar, Transfusion Medicine, Dhaka Medical College Hospital, Dhaka
2 shared publications- Ashraful Hoque
Department of Transfusion Medicine, Comilla Medical College Hospital, Cumilla, Bangladesh
1 shared publication - Kashfia Islam
Medical Officer, Department of Transfusion Medicine, Shaheed Sohrawardi Medical College & Hospital
1 shared publication
Latest Publications
- Open Access
- 14 May 2025
- Published by Bangladesh Academy of Sciences in Pulse
- Vol. 16 (2) , 27-30
Therapeutic plasma exchange in Graves’ disease – A Case Report
Therapeutic plasma exchange (TPE) is one possible treatment for patients resistant to conventional antithyroid drugs or requiring urgent attention for thyrotoxicosis. We report a 26-yr-old man with thyrotoxicosis, ultimately attributed to Graves’ disease in whom antithyroid drug used initially was soon discontinued, due to agranulocytosis. Due to the agranulocytosis, antithyroid drugs were not an option, so radioactive iodine (RAI) treatment was the next resort. Unfortunately, the free thyroid hormone level was still elevated and euthyroid state was required prior to RAI treatment, so another strategy was needed to correct the thyroid function. So, we performed TPE to control the thyrotoxicosis. Pulse Volume 16, Issue 2 2024, P: 27-30
- 14 May 2025
- Published by Bangladesh Academy of Sciences in Pulse
- Vol. 16 (2) , 27-30
Open AccessTherapeutic plasma exchange in Graves’ disease – A Case Report
Therapeutic plasma exchange (TPE) is one possible treatment for patients resistant to conventional antithyroid drugs or requiring urgent attention for thyrotoxicosis. We report a 26-yr-old man with thyrotoxicosis, ultimately attributed to Graves’ disease in whom antithyroid drug used initially was soon discontinued, due to agranulocytosis. Due to the agranulocytosis, antithyroid drugs were not an option, so radioactive iodine (RAI) treatment was the next resort. Unfortunately, the free thyroid hormone level was still elevated and euthyroid state was required prior to RAI treatment, so another strategy was needed to correct the thyroid function. So, we performed TPE to control the thyrotoxicosis. Pulse Volume 16, Issue 2 2024, P: 27-30
- Open Access
- 31 December 2024
- Published by Medip Academy in International Journal of Research in Medical Sciences
- Vol. 13 (1) , 62-66
Frequency of autoantibody formation in multi-transfused thalassemia patients at a tertiary care hospital: a cross-sectional study
Background: Autoantibodies are produced by the immune system against the body’s own proteins, such as red blood cells, particularly after transfusions. This phenomenon, known as erythrocyte autoimmunization, has been a recognized complication of repeated transfusions. The purpose of this study was to evaluate the frequency of autoantibody formation in multi-transfused thalassemia patients at a tertiary care hospital. The aim of the study was to detect the frequency of autoantibody formation in multi-transfused thalassemia patients at a tertiary care hospital. Methods: This cross-sectional study at the department of transfusion medicine, BSMMU, Dhaka, conducted from October 2017 to September 2018, included 384 thalassemia patients who received at least 10 units of red cell concentrate. Informed consent was obtained, and data collection involved patient interviews, clinical exams, and hematological tests. Statistical analysis using SPSS version 23.0 included Chi-square, Fisher’s exact, and t-tests, with significance set at p<0.05. Results: In the study of 384 patients, 43.5% were under 10 years old, with a majority of 52.9% male. Coombs’ test showed 3.1% DCT positive, 7.5% ICT positive, and 4.2% positive for both. All 12 DCT-positive patients had a history of drug use, and 7.7% had undergone splenectomy. Conclusions: In conclusion, regular blood transfusion in thalassemia patients is a key factor in autoimmunization, with lower antibody formation in females, younger patients, and those with blood group B, while Rh phenotype-matched blood and prestorage leukodepletion may help reduce autoantibody formation.
- 31 December 2024
- Published by Medip Academy in International Journal of Research in Medical Sciences
- Vol. 13 (1) , 62-66
Open AccessFrequency of autoantibody formation in multi-transfused thalassemia patients at a tertiary care hospital: a cross-sectional study
Background: Autoantibodies are produced by the immune system against the body’s own proteins, such as red blood cells, particularly after transfusions. This phenomenon, known as erythrocyte autoimmunization, has been a recognized complication of repeated transfusions. The purpose of this study was to evaluate the frequency of autoantibody formation in multi-transfused thalassemia patients at a tertiary care hospital. The aim of the study was to detect the frequency of autoantibody formation in multi-transfused thalassemia patients at a tertiary care hospital. Methods: This cross-sectional study at the department of transfusion medicine, BSMMU, Dhaka, conducted from October 2017 to September 2018, included 384 thalassemia patients who received at least 10 units of red cell concentrate. Informed consent was obtained, and data collection involved patient interviews, clinical exams, and hematological tests. Statistical analysis using SPSS version 23.0 included Chi-square, Fisher’s exact, and t-tests, with significance set at p<0.05. Results: In the study of 384 patients, 43.5% were under 10 years old, with a majority of 52.9% male. Coombs’ test showed 3.1% DCT positive, 7.5% ICT positive, and 4.2% positive for both. All 12 DCT-positive patients had a history of drug use, and 7.7% had undergone splenectomy. Conclusions: In conclusion, regular blood transfusion in thalassemia patients is a key factor in autoimmunization, with lower antibody formation in females, younger patients, and those with blood group B, while Rh phenotype-matched blood and prestorage leukodepletion may help reduce autoantibody formation.
- Open Access
- 30 September 2024
- Published by Medip Academy in International Journal of Research in Medical Sciences
- Vol. 12 (10) , 3656-3660
Correlation between blood group and autoantibodies formation in multi-transfused thalassaemia patients
Background: Thalassemia is a prevalent genetic disorder of hemoglobin synthesis, characterized by reduced production or absence of one or more globin chains, requiring frequent blood transfusions that can lead to complications such as autoantibody formation. The purpose of this study was to assess the correlation between blood group and the formation of autoantibodies in thalassemia patients who have received multiple blood transfusions. Methods: This cross-sectional study at the Department of Transfusion Medicine, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, conducted from October 2017 to September 2018, included 384 thalassemia patients who received at least 10 units of red cell concentrate. Participants were selected based on specific inclusion and exclusion criteria, with informed consent obtained. Data collection involved patient interviews, clinical examinations, and hematological tests. Statistical analysis using SPSS version 23.0 included Chi-square, Fisher’s exact, and t-tests, with significance set at p<0.05. Results: Among 384 patients, the most common blood group was B+ (46.2%). Coombs' test results showed DCT positivity in 3.1% of 384 patients, ICT positivity in 7.5%, and both DCT and ICT in 4.2%. Most patients (92.3%) had their first transfusion after age 2, with 84.6% receiving transfusions every 2-4 weeks. Conclusions: In conclusion, B positive blood group thalassemia patients receiving frequent transfusions are at a higher risk of autoantibody formation, and Rhesus phenotype-matched blood with pre-storage leukodepletion is recommended to mitigate this risk.
- 30 September 2024
- Published by Medip Academy in International Journal of Research in Medical Sciences
- Vol. 12 (10) , 3656-3660
Open AccessCorrelation between blood group and autoantibodies formation in multi-transfused thalassaemia patients
Background: Thalassemia is a prevalent genetic disorder of hemoglobin synthesis, characterized by reduced production or absence of one or more globin chains, requiring frequent blood transfusions that can lead to complications such as autoantibody formation. The purpose of this study was to assess the correlation between blood group and the formation of autoantibodies in thalassemia patients who have received multiple blood transfusions. Methods: This cross-sectional study at the Department of Transfusion Medicine, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, conducted from October 2017 to September 2018, included 384 thalassemia patients who received at least 10 units of red cell concentrate. Participants were selected based on specific inclusion and exclusion criteria, with informed consent obtained. Data collection involved patient interviews, clinical examinations, and hematological tests. Statistical analysis using SPSS version 23.0 included Chi-square, Fisher’s exact, and t-tests, with significance set at p<0.05. Results: Among 384 patients, the most common blood group was B+ (46.2%). Coombs' test results showed DCT positivity in 3.1% of 384 patients, ICT positivity in 7.5%, and both DCT and ICT in 4.2%. Most patients (92.3%) had their first transfusion after age 2, with 84.6% receiving transfusions every 2-4 weeks. Conclusions: In conclusion, B positive blood group thalassemia patients receiving frequent transfusions are at a higher risk of autoantibody formation, and Rhesus phenotype-matched blood with pre-storage leukodepletion is recommended to mitigate this risk.
- Open Access
- 14 July 2022
- Published by MDPI AG in Preprints.org
Prevalence of Anti-DENV IgG Among Routine Bangladeshi Blood Donors, and Strategies for the Future
Background: Dengue is the most common arthropod-borne sickness worldwide, impacting at least 50 million people each year. The dengue virus has four primary serotypes. Infection with one serotype confers homotypic immunity but not heterologous immunity, and secondary infections may be more severe. Although blood transfusions and organ donations have also been observed, the Aedes aegypti mosquito is the primary vector for the transmission of dengue. Infection causes a continuum of clinical illness, from asymptomatic infection to dengue fever, DHF, and dengue shock syndrome (DSS).Aim: To assess the presence of anti DENV IgG and anti DENV IgM antibodies specific to the four dengue serotypes in blood donor service donors and the importance of pre-donation screening in routine blood collection procedures.Method: 3 mL of peripheral venous blood from 507 blood donors was collected in tubes with BD vacutainer gel tube for serum separation after epidemiological records were reviewed. After that, serum was separated and tests were performed by SD Bioline Dengue Duo. Participants in the study completed a social and epidemiological questionnaire that contained information such as age, gender, and dengue diagnosis.Result: Out of the 507 blood samples that were taken, 473 (93.3%) came from male blood donors, while the remaining 34 (6.7%) belonged to female blood donors. The ratio of males to females is 13.91 to 1. The age range is 18–60 years, and the mean and standard deviation are both 27.7 and 6.5. 183 of the 507 samples produced anti DENV IgG positivity, while 324 did not. The ratio of positive to negative was 1.25:2.Conclusion: According to the findings of this study, quantitative methods for determining the presence of anti-dengue antibodies or detecting the dengue virus in blood donors in endemic areas should be devised in order to ensure the quality of blood transfusions.
- 14 July 2022
- Published by MDPI AG in Preprints.org
Open AccessPrevalence of Anti-DENV IgG Among Routine Bangladeshi Blood Donors, and Strategies for the Future
Background: Dengue is the most common arthropod-borne sickness worldwide, impacting at least 50 million people each year. The dengue virus has four primary serotypes. Infection with one serotype confers homotypic immunity but not heterologous immunity, and secondary infections may be more severe. Although blood transfusions and organ donations have also been observed, the Aedes aegypti mosquito is the primary vector for the transmission of dengue. Infection causes a continuum of clinical illness, from asymptomatic infection to dengue fever, DHF, and dengue shock syndrome (DSS).Aim: To assess the presence of anti DENV IgG and anti DENV IgM antibodies specific to the four dengue serotypes in blood donor service donors and the importance of pre-donation screening in routine blood collection procedures.Method: 3 mL of peripheral venous blood from 507 blood donors was collected in tubes with BD vacutainer gel tube for serum separation after epidemiological records were reviewed. After that, serum was separated and tests were performed by SD Bioline Dengue Duo. Participants in the study completed a social and epidemiological questionnaire that contained information such as age, gender, and dengue diagnosis.Result: Out of the 507 blood samples that were taken, 473 (93.3%) came from male blood donors, while the remaining 34 (6.7%) belonged to female blood donors. The ratio of males to females is 13.91 to 1. The age range is 18–60 years, and the mean and standard deviation are both 27.7 and 6.5. 183 of the 507 samples produced anti DENV IgG positivity, while 324 did not. The ratio of positive to negative was 1.25:2.Conclusion: According to the findings of this study, quantitative methods for determining the presence of anti-dengue antibodies or detecting the dengue virus in blood donors in endemic areas should be devised in order to ensure the quality of blood transfusions.